134 related articles for article (PubMed ID: 1127583)
21. Pharmacokinetics of topically applied ophthalmic drugs.
Shell JW
Surv Ophthalmol; 1982; 26(4):207-18. PubMed ID: 7041308
[TBL] [Abstract][Full Text] [Related]
22. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.
Akpek EK; Vittitow J; Verhoeven RS; Brubaker K; Amar T; Powell KD; Boyer JL; Crean C
J Ocul Pharmacol Ther; 2009 Oct; 25(5):433-9. PubMed ID: 19857105
[TBL] [Abstract][Full Text] [Related]
23. Nasolacrimal stimulation of aqueous tear production.
Gupta A; Heigle T; Pflugfelder SC
Cornea; 1997 Nov; 16(6):645-8. PubMed ID: 9395874
[TBL] [Abstract][Full Text] [Related]
24. Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin.
Di Colo G; Zambito Y; Burgalassi S; Nardini I; Saettone MF
Int J Pharm; 2004 Apr; 273(1-2):37-44. PubMed ID: 15010128
[TBL] [Abstract][Full Text] [Related]
25. Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine.
Camber O; Edman P
Curr Eye Res; 1989 Jun; 8(6):563-7. PubMed ID: 2743795
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of topically applied pilocarpine in the albino rabbit eye.
Makoid MC; Robinson JR
J Pharm Sci; 1979 Apr; 68(4):435-43. PubMed ID: 438963
[TBL] [Abstract][Full Text] [Related]
27. Effect of topical pilocarpine treatment on tear production in dogs.
Smith EM; Buyukmihci NC; Farver TB
J Am Vet Med Assoc; 1994 Nov; 205(9):1286-9. PubMed ID: 7698938
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle.
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Biol Pharm Bull; 2000 Nov; 23(11):1352-6. PubMed ID: 11085365
[TBL] [Abstract][Full Text] [Related]
29. Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insert.
Gurtler F; Kaltsatos V; Boisramé B; Deleforge J; Gex-Fabry M; Balant LP; Gurny R
Pharm Res; 1995 Nov; 12(11):1791-5. PubMed ID: 8592688
[TBL] [Abstract][Full Text] [Related]
30. Aqueous chamber drug distribution volume measurement in rabbits.
Conrad JM; Robinson JR
J Pharm Sci; 1977 Feb; 66(2):219-24. PubMed ID: 839419
[TBL] [Abstract][Full Text] [Related]
31. [Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics].
Sun KX; Wang AP; Huang LJ; Liang RC; Liu K
Yao Xue Xue Bao; 2006 Nov; 41(11):1094-8. PubMed ID: 17262954
[TBL] [Abstract][Full Text] [Related]
32. General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.
Deng F; Ranta VP; Kidron H; Urtti A
Pharm Res; 2016 Nov; 33(11):2680-90. PubMed ID: 27431864
[TBL] [Abstract][Full Text] [Related]
33. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
Zhang L; Zhang J; Wang L; Xia H
Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573
[TBL] [Abstract][Full Text] [Related]
34. [Ocular pharmacokinetics and bioavailability of 0.2% ganciclovir in-situ gelling eye drops].
Zhang JJ; Gao CF; Wang LY
Zhonghua Yan Ke Za Zhi; 2006 Jul; 42(7):637-41. PubMed ID: 17081425
[TBL] [Abstract][Full Text] [Related]
35. Tear thinning time and topical anesthesia as assessed using the HIRCAL grid and the NCCA.
Blades KJ; Murphy PJ; Patel S
Optom Vis Sci; 1999 Mar; 76(3):164-9. PubMed ID: 10213446
[TBL] [Abstract][Full Text] [Related]
36. Vehicle effects on ocular drug bioavailability III: Shear-facilitated pilocarpine release from ointments.
Sieg JW; Robinson JR
J Pharm Sci; 1979 Jun; 68(6):724-8. PubMed ID: 458573
[TBL] [Abstract][Full Text] [Related]
37. Ocular penetration of topical chloramphenicol in humans.
Hanna C; Massey JY; Hendrickson RO; Williamson J; Jones EM; Wilson P
Arch Ophthalmol; 1978 Jul; 96(7):1258-61. PubMed ID: 666635
[TBL] [Abstract][Full Text] [Related]
38. Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.
Le Merdy M; Fan J; Bolger MB; Lukacova V; Spires J; Tsakalozou E; Patel V; Xu L; Stewart S; Chockalingam A; Narayanasamy S; Rouse R; Matta M; Babiskin A; Kozak D; Choi S; Zhang L; Lionberger R; Zhao L
AAPS J; 2019 May; 21(4):65. PubMed ID: 31111305
[TBL] [Abstract][Full Text] [Related]
39. Lacrimal and instilled fluid dynamics in rabbit eyes.
Chrai SS; Patton TF; Mehta A; Robinson JR
J Pharm Sci; 1973 Jul; 62(7):1112-21. PubMed ID: 4576801
[No Abstract] [Full Text] [Related]
40. Preparation and evaluation of HPMC-based pirfenidone solution in vivo.
Yang M; Yang YF; Lei M; Ye CT; Zhao CS; Xu JG; Wu KL; Yu MB
Drug Dev Ind Pharm; 2017 Jan; 43(1):171-176. PubMed ID: 27593737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
